| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4219772 | Academic Radiology | 2009 | 11 Pages |
Abstract
Because of its tumor targeting specificity, deliver of an MRI contrast agent via this nanocomplex has potential for use as an agent that can identify small lung cancers, thus improving early detection and possibly increasing survival.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Matthew MD, MBA, Esther H. PhD, Qi MSc, Kathleen F. PhD,